Tiedemann Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-73,129
Closed -$196K 277
2017
Q4
$196K Buy
+73,129
New +$196K 0.02% 214
2017
Q3
Sell
-73,129
Closed -$242K 492
2017
Q2
$242K Buy
73,129
+39,698
+119% +$131K 0.02% 393
2017
Q1
$140K Hold
33,431
0.01% 379
2016
Q4
$136K Buy
+33,431
New +$136K 0.01% 308